NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/04/2025
Back to search
Official data from USPTO
NANO-CNS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NANO-CNS
ST13
US500000098162138Class
40, 42
Filing
98162138
Registration
8014586
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
11/04/2025
Trademark type
Word
Nice classes
40, 42
Filing date
09/01/2023
Registration date
11/04/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/04/2025
Last transaction
11/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/05/2024
First use in commerce
12/05/2024
Drawing code
4
Owner type
03
Owner location
San Diego, CA, US
Examiner
RHIM,ANDREW
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Nano PharmaSolutions, Inc.
Representatives
Barry F. Soalt PROCOPIO CORY HARGREAVES & SAVITCH LLP
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom manufacture of pharmaceuticals and molecular drugs
Class 42
Research and formulation development in the pharmaceuticals and molecular drugs fields; Pharmaceutical drug development services; pharmaceutical products development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research in the field of generation of nano drug particles used to enhance the bioavailability of otherwise poorly soluble drugs; Scientific study and research in the fields of drug delivery and development of pharmaceuticals comprised of nano drug particles; Testing of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/04/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/16/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/16/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/15/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/15/2025
IUAF
USE AMENDMENT FILED
05/12/2025
EISU
TEAS STATEMENT OF USE RECEIVED
05/12/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/04/2025
EX1G
SOU EXTENSION 1 GRANTED
01/17/2025
EXT1
SOU EXTENSION 1 FILED
01/16/2025
EEXT
SOU TEAS EXTENSION RECEIVED
01/16/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/23/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/28/2024
PUBO
PUBLISHED FOR OPPOSITION
05/28/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/08/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/22/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/19/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/19/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/19/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/20/2024
GNRT
NON-FINAL ACTION E-MAILED
02/20/2024
CNRT
NON-FINAL ACTION WRITTEN
02/20/2024
DOCK
ASSIGNED TO EXAMINER
02/16/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/27/2023
NWAP
NEW APPLICATION ENTERED
09/05/2023
Continuous trademark protection
Get notified about every new filing that threatens NANO-CNS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.